Skip to main content
Clinical Trials/ACTRN12623001262695
ACTRN12623001262695RecruitingUnknown

High flow nasal oxygen therapy versus conventional oxygen therapy in patients undergoing bronchoscopy and the effect on oxygenation: a randomised controlled trial

Georgia Burton0 sites120 target enrollmentStarted: December 5, 2023Last updated:

Trial Snapshot

Phase
Unknown
Status
Recruiting
Sponsor
Enrollment
120

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Open (masking not used)

Eligibility Criteria

Ages
18 Years to o limit (—)
Sex
All

Inclusion Criteria

  • Age 18 years or older
  • Indication for diagnostic bronchoscopy (standard bronchoscopy or EBUS guided)
  • Pre-procedure intent to insert bronchoscope via the nose in the standard bronchoscopy group (stratum one)

Exclusion Criteria

  • Not able to consent
  • Patient is in ICU
  • Patient is in theatre
  • Patient is intubated
  • Patient has a tracheostomy
  • Pre-procedure intent to insert bronchoscope via the mouth in the standard bronchoscopy group (stratum one)

Investigators

Sponsor
Georgia Burton

Similar Trials

Oxygen delivery devices in bronchoscopy... | Clinical Trial